CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,892,000 | -9.7% | 200,000 | 0.0% | 0.64% | -7.7% |
| Q2 2023 | $6,524,000 | -7.0% | 200,000 | -2.4% | 0.69% | -10.6% |
| Q1 2023 | $7,013,050 | -29.2% | 205,000 | -5.2% | 0.77% | -25.5% |
| Q4 2022 | $9,911,874 | +8.1% | 216,322 | +3.0% | 1.03% | +7.7% |
| Q3 2022 | $9,169,000 | +1.5% | 210,000 | -8.7% | 0.96% | -6.5% |
| Q2 2022 | $9,037,000 | -16.8% | 230,000 | -22.0% | 1.03% | -4.1% |
| Q1 2022 | $10,859,000 | +58.8% | 295,000 | +96.7% | 1.07% | +135.4% |
| Q4 2021 | $6,840,000 | – | 150,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |